Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, E Van Cutsem, Y Narita, et al.
ESMO Open|January 28, 2026
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohortE Terán, R Pazo, L Caritá, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSOL-T Chen, E Martinelli, A-L Cheng, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Immuno-Oncology Technology|February 6, 2025
Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancersJ Palomero, V Galvao, I Creus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Open|July 29, 2026
Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort studyG Serna, M Obón-Santacana, I Baraibar, et al.
Pageof 18